RB plc, the leading global consumer health and hygiene company, has today completed the demerger of its speciality pharmaceuticals business Indivior, with shares in the separate company now trading on the London Stock Exchange.
RB Chief Executive Rakesh Kapoor said: “RB has now completed the demerger of Indivior. We wish the company well and believe that both businesses will benefit from being able to focus on their core competencies. RB will continue to pursue its strategy of being a global leader in the Health, Hygiene and Home categories.”
RB will announce its preliminary results on February 11, 2015.
For further information, please contact:
RB - +44 (0)1753 217800
Director, Investor Relations
Director External Comms
Brunswick - +44 (0)20 7404 5959
RB Demerger Advice NoteDownload PDF